NIH-funded research R21 grant

Investigating how the p53 protein affects learning and memory in the brain.

Official title: The tumor suppressor p53 in hippocampal plasticity and intellectual disability

Funded at University of Illinois at Urbana-Champaign · NIH-11077881 · Data updated 2026-11-12

This study is looking at how a protein called p53 in a part of the brain important for learning and memory affects memory formation, and it aims to help us understand how problems with this protein might lead to intellectual disabilities.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Illinois at Urbana-Champaign
NIH-funded
Lab location1 site (Champaign, United States)
Project startApril 23, 2024
Project endMarch 31, 2026
Funding year2025
Award (this year)$198,250
NIH project number5R21NS135779-02
Project IDNIH-11077881 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with intellectual disabilities or those at risk for such conditions due to genetic factors.

Less likely to help

Patients without intellectual disabilities or those not affected by p53-related conditions may not benefit from this research.

What this research studies

This research explores the role of the p53 protein in the hippocampus, a brain region crucial for learning and memory. It examines how changes in p53 levels influence the process of long-term potentiation (LTP), which is essential for forming memories. By studying mouse models, the research aims to understand how dysregulation of p53 may contribute to intellectual disabilities. The approach includes manipulating p53 levels in neurons to observe effects on synaptic plasticity and behavior.

Why it matters

Potential benefit: If successful, this research could lead to new insights and treatments for intellectual disabilities linked to p53 dysregulation.

How similar studies have gone: Previous research has shown promising results in understanding the role of transcription factors like p53 in brain function, indicating potential for success in this area.

Where this research is happening

  • University of Illinois at Urbana-Champaign
    Champaign, United States
    Active

Researchers

  • Principal investigator: Tsai, Nien-Pei — University of Illinois at Urbana-Champaign
  • Study coordinator: Tsai, Nien-Pei

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.